Citation only
via Europe PMC
A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.
Ageing research reviews · 2026
Cellular senescence
Altered intercellular communication
Chronic inflammation
Partial reprogramming (OSK)
Human
Preclinical / animal
Review
Abstract
Cellular senescence(definition) is a hallmark of aging and a contributing factor to many age-related morbidity and decline. A key characteristic of senescent cells is a pro-inflammatory secretome known as the senescence-associated secretory phenotype (SASP). When tracked in circulation, SASP factors associate with age-related clinical traits and diseases, raising the captivating possibility that the senescence burden, and concomitant susceptibility to age-related morbidity, can be noninvasively assessed in clinical settings. This review consolidates human-focused evidence identifying these biomarkers of senescence in circulation, and emerging drug and lifestyle-based senotherapeutic interventions that modulate senescence burden and associated clinical parameters. Clinical parameters associated with the circulating senescence burden generally fall into four interrelated health domains: neurodegeneration, pulmonary disease, cardiometabolic disease, and musculoskeletal disorders. For each domain, the biological basis for the negative impact of senescence is explored in clinical and preclinical models, revealing that the accumulation of senescence often suppresses stemness throughout the body, suggesting that senescence plays a causal role in age-related decline and highlighting potential novel therapeutic avenues. Importantly, some circulating biomarkers of senescence, such as GDF15 and Activin A, demonstrate cross-study clinical relevance and are implicated in morbidities across multiple health domains. Collectively, these insights provide a framework for understanding the role that senescence plays in aging and the development of diagnostic biomarker panels that could better inform future clinical care.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.arr.2026.103254
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
B, O., & N., B. (2026). A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions. <em>Ageing research reviews</em>. https://doi.org/10.1016/j.arr.2026.103254
Vancouver
B O, N. B. A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions. Ageing research reviews. 2026. doi:10.1016/j.arr.2026.103254.
BibTeX
@article{olinger2026Acompe,
title = {A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.},
author = {Olinger B and Basisty N.},
journal = {Ageing research reviews},
year = {2026},
doi = {10.1016/j.arr.2026.103254},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Opinion in Clinical Nutrition & Metabolic Care 2014
Citation only
Cellular senescence and the senescent secretory phenotype in age-related chronic diseases
Frontiers in Pharmacology 2020
Open access · CC-BY
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Arthritis Research & Therapy 2022
Open access · CC-BY
Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis
Chinese Medical Journal 2025
Open access · CC-BY
Cellular senescence in renal ischemia-reperfusion injury
Pharmaceuticals 2025
Open access · CC-BY
Cellular Senescence in Health, Disease, and Lens Aging
PubMed 2024
Preprint